Nature's Sunshine Q1 2026: Sales and EBITDA Surge, But Valuation Remains Stretched

What happened

Nature's Sunshine reported Q1 2026 net sales of $122.9M, up 9% YoY, with GAAP EPS rising 16% to $0.29 and adjusted EBITDA jumping 33% to $14.6M, accelerating the margin expansion noted in the company's 2025 filings. The results beat the trajectory implied by the prior DeepValue report, which had flagged improving fundamentals but still saw the stock as overvalued given a 47% run-up and a P/E of ~25.7x. Despite the strong quarter, the stock trades at ~$21.98, roughly 109% above a conservative DCF estimate of $10.52, leaving limited margin of safety. The improvement is real but stems from the same narrow-moat, MLM-dependent model that carries regulatory and FX risks, as detailed in the report. Thus, while execution is commendable, the risk/reward at current levels remains unfavorable for value investors.

Implication

The Q1 beat reinforces that Nature's Sunshine is executing well, with accelerating sales and margin expansion that could support higher earnings in 2026. However, the stock's 47% 12-month rally has already priced in much of this improvement, leaving it trading at 25.7x trailing earnings and 109% above a conservative DCF value. The DeepValue report's caution on the narrow moat, MLM regulatory overhang, and thin net margins remains fully intact. For long-term holders, the quarter provides an opportunity to trim positions at elevated multiples rather than add. New investors should wait for a more attractive entry point, ideally near or below the ~$10.52 intrinsic estimate, to account for the inherent risks.

Thesis delta

The strong Q1 2026 results confirm the operational turnaround highlighted in the DeepValue report, with sales growth and margin expansion exceeding prior expectations. However, this does not narrow the wide gap between market price and conservative intrinsic value; the stock remains overvalued. The thesis therefore shifts from 'potential sell' to a more definitive 'sell' on strength, as the near-term good news is already baked into the share price.